Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Strata Critical Medical (SRTA) Other Operating Expenses (2019 - 2025)

Historic Other Operating Expenses for Strata Critical Medical (SRTA) over the last 7 years, with Q3 2025 value amounting to $38.2 million.

  • Strata Critical Medical's Other Operating Expenses rose 3220.87% to $38.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $247.5 million, marking a year-over-year increase of 4797.51%. This contributed to the annual value of $197.7 million for FY2024, which is 218.51% up from last year.
  • According to the latest figures from Q3 2025, Strata Critical Medical's Other Operating Expenses is $38.2 million, which was up 3220.87% from $54.7 million recorded in Q2 2025.
  • In the past 5 years, Strata Critical Medical's Other Operating Expenses registered a high of $110.8 million during Q4 2024, and its lowest value of $8.4 million during Q1 2021.
  • Its 5-year average for Other Operating Expenses is $39.8 million, with a median of $38.3 million in 2022.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first soared by 567688.97% in 2021, then crashed by 5069.43% in 2024.
  • Over the past 5 years, Strata Critical Medical's Other Operating Expenses (Quarter) stood at $22.1 million in 2021, then soared by 61.47% to $35.6 million in 2022, then grew by 14.79% to $40.9 million in 2023, then surged by 171.14% to $110.8 million in 2024, then tumbled by 65.57% to $38.2 million in 2025.
  • Its Other Operating Expenses was $38.2 million in Q3 2025, compared to $54.7 million in Q2 2025 and $43.8 million in Q1 2025.